SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Camlin Fine Sciences gets nod to raise Rs 150 crore

24 Nov 2017 Evaluate

Camlin Fine Sciences has received an approval to issue and allot  1,72,41,379 Equity Shares of face value Re 1 each to eligible qualified institutional buyers at the issue price of Rs 87 per Equity Share, aggregating to Rs 150 crore. The Security Issue and QIP Committee of the Company at its meeting held on November 23, 2017, approved the same.

Camlin Fine Sciences is the world's second largest manufacturer and marketer of food grade antioxidants BHA (butylated hydroxyanisole) and TBHQ (Tertiary Butylhydroquinone).

Camlin Fine Sciences Share Price

131.50 4.53 (3.57%)
04-May-2026 11:27 View Price Chart
Peers
Company Name CMP
BASF India 3736.15
Tata Chemicals 821.00
SRF 2556.35
Pidilite Inds. 1383.70
Deepak Nitrite 1736.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×